{"id":712,"date":"2026-01-22T02:33:28","date_gmt":"2026-01-22T00:33:28","guid":{"rendered":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&#038;p=712"},"modified":"2026-01-22T02:33:28","modified_gmt":"2026-01-22T00:33:28","slug":"mounjaro-vs-ozempic-milline-kaalu-langetamise-behandeling-on-sinu-eest-oige","status":"publish","type":"tty_blog","link":"https:\/\/www.transtoyou.com\/et\/blog\/krooniline-metaboolne-tervis\/mounjaro-vs-ozempic-milline-kaalu-langetamise-behandeling-on-sinu-eest-oige\/","title":{"rendered":"Mounjaro vs Ozempic: Milline kaalulangetamise ravi sobib sulle?"},"content":{"rendered":"<p>Kui olete otsinud uusi viise kaalulangetamiseks, on suur t\u00f5en\u00e4osus, et olete kokku puutunud nimedega Mounjaro ja Ozempic. M\u00f5lemad on retseptiravimid, mis on spetsiaalselt loodud 2. t\u00fc\u00fcpi diabeedi kontrollimiseks. Kuid v\u00e4ga kiiresti said need ravimid populaarseks ka teisel eesm\u00e4rgil: suure kaalukaotuse saavutamiseks.&nbsp;<\/p>\n<p>Uuringud n\u00e4itavad silmatorkavaid tulemusi: uuringus avastati, et rohkem kui 80% Mounjaro kasutajatest kaotas v\u00e4hemalt 5% oma kehakaalust aasta jooksul, v\u00f5rreldes umbes 66% Ozempic kasutajatest. Aga mis on parim just sinu jaoks? Selgitame seda lihtsalt ja selgelt.<\/p>\n<h2>Mis on Mounjaro ja Ozempic?<\/h2>\n<p>M\u00f5lemad <a class=\"always-open-new-tab\"   href=\"\/et\/product\/ozempic\"   rel=\"nofollow\">Ozempic<\/a> ja <a class=\"always-open-new-tab\"   href=\"\/et\/product\/mounjaro\"   rel=\"nofollow\">Mounjaro<\/a> on retseptiravimid, mis on algselt m\u00f5eldud vere gl\u00fckoositaseme kontrollimiseks 2. t\u00fc\u00fcpi <a class=\"always-open-new-tab\"   href=\"\/et\/treatment\/diabetes\"   rel=\"nofollow\">diabeedi<\/a> korral. Aja jooksul on nad aga muutunud populaarseks ka teisel eesm\u00e4rgil, kaalulangetamiseks. Need ravimid kuuluvad ravimite klassi, mida tuntakse kui GLP-1 retseptori agonistid.&nbsp;<\/p>\n<p>Lihtsalt \u00f6eldes matkivad nad teatud hormoone, mida keha vabastab loomulikult p\u00e4rast s\u00f6\u00f6ki. T\u00f5epoolest, miljonid inimesed on juba kasutanud GLP-1 ravimeid nagu Ozempic, Mounjaro ja <a class=\"always-open-new-tab\"   href=\"\/et\/product\/wegovy\"   rel=\"nofollow\">Wegovy<\/a> kaalulangetamiseks v\u00f5i diabeedi kontrollimiseks.<\/p>\n<p>Kuigi Ozempic on heaks kiidetud ainult 2. t\u00fc\u00fcpi diabeedi jaoks (mitte kaalulangetamiseks), on Mounjaro heaks kiidetud nii diabeedi juhtimiseks kui ka <a class=\"always-open-new-tab\"   href=\"\/et\/treatment\/weight-loss\"   rel=\"nofollow\">kaalulangetamise raviks<\/a>.<\/p>\n<h2>Nii need toimivad<\/h2>\n<p>Need panevad su k\u00f5hun\u00e4\u00e4rme eritama rohkem insuliini, kui su vere gl\u00fckoositasemed on liiga k\u00f5rged, ja v\u00e4hendavad teise hormooni, gl\u00fckagooni, taset, mis v\u00f5ib t\u00f5sta vere gl\u00fckoositaset. Need v\u00e4hendavad ka toidu liikumise kiirus k\u00f5hus, nii et sa tunned end kauem t\u00e4is. See aitab mitte ainult diabeedi kontrolli all hoida; see toetab ka stabiilset kaalulangust.<\/p>\n<h2>Mounjaro vs. Ozempic kaalulangetamiseks<\/h2>\n<p>M\u00f5lemad Mounjaro ja Ozempic on diabeediravimid, kuid on ka huvi kaalulangetamise osas. Need toimivad, j\u00e4ttes sind kauem t\u00e4isoleku tundesse, nii et sa s\u00f6\u00f6d loomulikult v\u00e4hem.<\/p>\n<p>Ozempic matkib \u00fchte hormooni, samas kui Mounjaro matkib kahte, seega on see kaalulangetamisel veidi t\u00f5husam. T\u00f5epoolest, \u00fches uuringus kaotasid Mounjaro maksimaalse annuse saanud isikud rohkem kui 20% oma kehakaalust. Ozempic&#8217;i kasutavad isikud kaotavad tavaliselt umbes 10%\u201315%, kuigi m\u00f5ned kaotavad veidi rohkem.<\/p>\n<h2>Samad ja erinevad omadused Mounjaro ja Ozempic vahel<\/h2>\n<table>\n<thead>\n<tr>\n<th>Omadus<\/th>\n<th>Mounjaro<\/th>\n<th>Ozempic<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mida nad teevad<\/td>\n<td>Alandab vere gl\u00fckoositaset, aitab kaalulangetamisel ja v\u00f5ib v\u00e4hendada s\u00fcdame riske<\/td>\n<td>Alandab vere gl\u00fckoositaset, aitab kaalulangetamisel, v\u00e4hendab s\u00fcdameataki ja insuldi riski<\/td>\n<\/tr>\n<tr>\n<td>Kuidas nad toimivad<\/td>\n<td>Toimib nagu kaks looduslikku hormooni (GIP + GLP-1)<\/td>\n<td>Toimib nagu \u00fcks hormoon (GLP-1)<\/td>\n<\/tr>\n<tr>\n<td>Kaalulangetamise tulemused<\/td>\n<td>T\u00f5husam; ~80% kaotab \u22655% kehakaalust, ~36% kaotab \u226515%<\/td>\n<td>Less effective; ~54% kaotab \u22655%, ~8% kaotab \u226515%<\/td>\n<\/tr>\n<tr>\n<td>Kuidas seda v\u00f5tta<\/td>\n<td>N\u00e4dalane s\u00fcst; \u00fchekordselt kasutatavad pliiatsid (2.5\u201315 mg s\u00f5ltuvalt retseptist)<\/td>\n<td>N\u00e4dalane s\u00fcst; pliiats sisaldab 4 annust (0.25\u20132 mg) kuu jooksul<\/td>\n<\/tr>\n<tr>\n<td>K\u00f5rvaltoimed<\/td>\n<td>Iiveldus, oksendamine, k\u00f5huvalu, k\u00f5hulahtisus, k\u00f5hukinnisus, seedeh\u00e4ired (sama nagu Ozempic)<\/td>\n<td>Iiveldus, oksendamine, k\u00f5huvalu, k\u00f5hulahtisus, k\u00f5hukinnisus, seedeh\u00e4ired (sama nagu Mounjaro)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Erinevused nende toimimises: GIP + GLP-1 vs GLP-1<\/h2>\n<p>Suur erinevus Mounjaro ja Ozempic vahel on see, kui palju hormoone nad matkivad.<\/p>\n<ul>\n<li>Mounjaro sihib nii GIP kui ka GLP-1 retseptoreid. See kahefoolne toime v\u00f5ib parandada vere gl\u00fckoositaseme kontrolli ja suurendada kaalulangust.<\/li>\n<li>Ozempic sihib ainult GLP-1 retseptorit. See toimib endiselt paljudele inimestele h\u00e4sti, kuid tal puudub GIP-i lisatoime.<\/li>\n<\/ul>\n<p>M\u00f5tle sellele nii: Mounjaro on nagu kahe t\u00f6\u00f6riista kasutamine korraga, et t\u00f6\u00f6 tehtud saada \u2014 samas kui Ozempic kasutab \u00fchte. M\u00f5lemad toimivad, kuid Mounjaro v\u00f5ib teatud juhtudel olla v\u00f5imsam.<\/p>\n<h2>Milline on kaalulangetamisel t\u00f5husam \u2014 Mounjaro v\u00f5i Ozempic?<\/h2>\n<p>Kui sind huvitab, milline neist on kaalulangetamisel t\u00f5husam, on l\u00fchike vastus: Mounjaro n\u00e4ib olevat eelisega.<\/p>\n<p>Suur uuring 2024. aastal uuris rohkem kui 41 000 t\u00e4iskasvanut, kellel on 2. t\u00fc\u00fcpi diabeet, ja avastas:&nbsp;<\/p>\n<ul>\n<li>Umbes 82% Mounjaro (Tirzepatide) kasutajatest kaotas v\u00e4hemalt 5% oma kehakaalust \u00fche aasta jooksul.<\/li>\n<li>Umbes 67% Ozempic (Semaglutide) kasutajatest saavutas samuti sama kaalulangetamise piiri.<\/li>\n<\/ul>\n<p>Ja nii, keskmiselt, p\u00f5hjustas Mounjaro kaalulanguse v\u00e4henemise umbes 7% v\u00f5rreldes Ozempic&#8217;iga 12 kuu jooksul, mis on v\u00e4ga oluline erinevus.<\/p>\n<p>Rohkem kui pooled igast grupist l\u00f5petasid ravimite kasutamise uuringu ajal. Miks see nii v\u00f5ib olla? K\u00f5rvaltoimed, kulud v\u00f5i isegi ravimite puudus on v\u00f5imalused; ei ole teada.<\/p>\n<p>Ja et sa oleksid teadlik: on olemas ka teisi kaalulangetamiseks m\u00f5eldud ravimeid, nagu Mysimba, Orlistat (Xenical), Orlistat 60 mg, Saxenda ja Wegovy. Kuid Mounjaro ja Ozempic paistavad silma, kuna need on algselt loodud diabeedi raviks ja avastati, et need aitavad kaalust alla v\u00f5tta.<\/p>\n<h2>Mounjaro ja Ozempic k\u00f5rvaltoimed: Mis on erinev?<\/h2>\n<h3>Ozempic&#8217;i tavalised k\u00f5rvaltoimed:&nbsp;<\/h3>\n<ul>\n<li>Haigustunne (iiveldus)<\/li>\n<li>Oksendamine<\/li>\n<li>K\u00f5hulahtisus<\/li>\n<li>K\u00f5hukinnisus<\/li>\n<li>K\u00f5huvalu<\/li>\n<\/ul>\n<h3>Mounjaro tavalised k\u00f5rvaltoimed:<\/h3>\n<ul>\n<li>Iiveldus<\/li>\n<li>K\u00f5hulahtisus<\/li>\n<li>Oksendamine<\/li>\n<li>Isu v\u00e4henemine<\/li>\n<li>K\u00f5huvalu<\/li>\n<li>K\u00f5hukinnisus<\/li>\n<li>Seedeh\u00e4ired<\/li>\n<\/ul>\n<h2>Millised patsiendid reageerivad Mounjaro&#8217;le paremini?<\/h2>\n<p>Mounjaro on tuntud selle poolest, et see toimib k\u00f5ige paremini 2. t\u00fc\u00fcpi diabeediga inimestel, kellel on ka kaaluga probleeme. See sihib kahte hormoonide teed, GIP ja GLP-1, ning sellel v\u00f5ib olla parem m\u00f5ju vere gl\u00fckoositaseme kontrollile ja kaalulangusele kui GLP-1 \u00fcksi ravimitega nagu Ozempic.<\/p>\n<p>Inimesed, kes on proovinud teisi ravimeetodeid ilma suurema eduta, v\u00f5ivad Mounjaro&#8217;ga olla edukamad. Tulemused varieeruvad alati. M\u00f5ned kogevad rohkem k\u00f5rvaltoimeid kui teised, ja m\u00f5ned v\u00f5ivad m\u00e4rgata v\u00e4ga v\u00e4he erinevusi.<\/p>\n<h2>Kulude v\u00f5rdlus: Mounjaro vs Ozempic<\/h2>\n<p>Mounjaro algab tavaliselt madalama kuu hinnaga, samas kui Ozempic maksab tavaliselt rohkem. Samuti on oluline m\u00e4rkida, et Ozempic ei ole heaks kiidetud kaalulangetamiseks, erinevalt Mounjaro&#8217;st, mida kasutatakse nii diabeedi kui ka kehakaalu juhtimiseks.<\/p>\n<p>Hinnad varieeruvad s\u00f5ltuvalt teie annusest, kindlustusest ja sellest, kas teil on \u00f5igus ravimifirmade s\u00e4\u00e4stuprogrammidele. On hea m\u00f5te v\u00f5tta \u00fchendust oma kindlustuse v\u00f5i apteegi h\u00fcvitistega, et teada, kui palju see tegelikult maksab.<\/p>\n<h2>Oluline kokkuv\u00f5te<\/h2>\n<p>Mounjaro ja Ozempic on m\u00f5lemad v\u00e4ga t\u00f5husad 2. t\u00fc\u00fcpi diabeedi ravimid ja aitavad kaalulangetamisel. Mounjaro n\u00e4ib omavat veidi suuremat m\u00f5ju, eriti kaalulangetamisel, kuid see on ka kallim. M\u00f5lemal ravimil on mao k\u00f5rvaltoimed ja need ei ole imeravimid.<\/p>\n<p>Transtoyou&#8217;s \u00fchendame teid arstide ja partnerapteekidega, muutes ravimite tellimise veebis lihtsaks, saades kaugelt arsti heakskiidu ja t\u00e4ites retsepte kiiresti, k\u00f5ik \u00fches sujuvas protsessis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kui olete otsinud uusi viise kaalulangetamiseks, on suur t\u00f5en\u00e4osus, et olete kokku puutunud nimedega Mounjaro ja Ozempic. M\u00f5lemad on retseptiravimid,&#8230;<\/p>\n","protected":false},"author":13,"featured_media":713,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"tags":[],"expert":[16],"tty_blog_category":[38],"tty_blog_tag":[],"class_list":["post-712","tty_blog","type-tty_blog","status-publish","has-post-thumbnail","hentry","expert-dr-c-alexandru","tty_blog_category-krooniline-metaboolne-tervis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mounjaro vs Ozempic: Erinevused ja T\u00f5husus - Transtoyou - ET<\/title>\n<meta name=\"description\" content=\"V\u00f5rdle Mounjaro ja Ozempic&#039;i kaalulangetamise ja II t\u00fc\u00fcbi diabeedi osas: efektiivsus, k\u00f5rvaltoimed, annustamine ja kulud.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mounjaro vs Ozempic: Erinevused ja T\u00f5husus - Transtoyou - ET\" \/>\n<meta property=\"og:description\" content=\"V\u00f5rdle Mounjaro ja Ozempic&#039;i kaalulangetamise ja II t\u00fc\u00fcbi diabeedi osas: efektiivsus, k\u00f5rvaltoimed, annustamine ja kulud.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&amp;p=712\" \/>\n<meta property=\"og:site_name\" content=\"Transtoyou - ET\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.transtoyou.com\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712\",\"url\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712\",\"name\":\"Mounjaro vs Ozempic: Erinevused ja T\u00f5husus - Transtoyou - ET\",\"isPartOf\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png\",\"datePublished\":\"2026-01-22T00:33:28+00:00\",\"description\":\"V\u00f5rdle Mounjaro ja Ozempic'i kaalulangetamise ja II t\u00fc\u00fcbi diabeedi osas: efektiivsus, k\u00f5rvaltoimed, annustamine ja kulud.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#primaryimage\",\"url\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png\",\"contentUrl\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png\",\"width\":1024,\"height\":1024,\"caption\":\"Mounjaro ja Ozempic s\u00fcstalde v\u00f5rdlus kaalulangetamise ikoonidega, kaaluga ja enne-p\u00e4rast figuuridega.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/#website\",\"url\":\"https:\/\/www.transtoyou.com\/et\/\",\"name\":\"Transtoyou - ET\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.transtoyou.com\/et\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/#organization\",\"name\":\"Transtoyou - ET\",\"url\":\"https:\/\/www.transtoyou.com\/et\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp\",\"contentUrl\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp\",\"width\":300,\"height\":87,\"caption\":\"Transtoyou - ET\"},\"image\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mounjaro vs Ozempic: Erinevused ja T\u00f5husus - Transtoyou - ET","description":"V\u00f5rdle Mounjaro ja Ozempic'i kaalulangetamise ja II t\u00fc\u00fcbi diabeedi osas: efektiivsus, k\u00f5rvaltoimed, annustamine ja kulud.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"et_EE","og_type":"article","og_title":"Mounjaro vs Ozempic: Erinevused ja T\u00f5husus - Transtoyou - ET","og_description":"V\u00f5rdle Mounjaro ja Ozempic'i kaalulangetamise ja II t\u00fc\u00fcbi diabeedi osas: efektiivsus, k\u00f5rvaltoimed, annustamine ja kulud.","og_url":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712","og_site_name":"Transtoyou - ET","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.transtoyou.com\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712","url":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712","name":"Mounjaro vs Ozempic: Erinevused ja T\u00f5husus - Transtoyou - ET","isPartOf":{"@id":"https:\/\/www.transtoyou.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#primaryimage"},"image":{"@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#primaryimage"},"thumbnailUrl":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png","datePublished":"2026-01-22T00:33:28+00:00","description":"V\u00f5rdle Mounjaro ja Ozempic'i kaalulangetamise ja II t\u00fc\u00fcbi diabeedi osas: efektiivsus, k\u00f5rvaltoimed, annustamine ja kulud.","breadcrumb":{"@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=712#primaryimage","url":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png","contentUrl":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/Weight-loss-5-image-11.png","width":1024,"height":1024,"caption":"Mounjaro ja Ozempic s\u00fcstalde v\u00f5rdlus kaalulangetamise ikoonidega, kaaluga ja enne-p\u00e4rast figuuridega."},{"@type":"WebSite","@id":"https:\/\/www.transtoyou.com\/et\/#website","url":"https:\/\/www.transtoyou.com\/et\/","name":"Transtoyou - ET","description":"","publisher":{"@id":"https:\/\/www.transtoyou.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.transtoyou.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/www.transtoyou.com\/et\/#organization","name":"Transtoyou - ET","url":"https:\/\/www.transtoyou.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp","contentUrl":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp","width":300,"height":87,"caption":"Transtoyou - ET"},"image":{"@id":"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog\/712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog"}],"about":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/types\/tty_blog"}],"author":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/comments?post=712"}],"version-history":[{"count":1,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog\/712\/revisions"}],"predecessor-version":[{"id":714,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog\/712\/revisions\/714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/media\/713"}],"wp:attachment":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/media?parent=712"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tags?post=712"},{"taxonomy":"expert","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/expert?post=712"},{"taxonomy":"tty_blog_category","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog_category?post=712"},{"taxonomy":"tty_blog_tag","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog_tag?post=712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}